Clinical outcome and independent predictor in acute heart failure treated with tolvaptan: retrospective analysis

Clinical outcome and independent predictor in acute heart failure treated with tolvaptan: retrospective analysis - Clinical outcome and independent predictor in acute heart failure treated with tolvaptan

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029416

Enrollment

300

Registered

2017-10-04

Start date

2017-10-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute heart failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: acute decompensated heart failure treated with tolvaptan between January 2012 and September 2015

Exclusion criteria

Exclusion criteria: the patients with malignant tumor

Design outcomes

Primary

Measure	Time frame
Cardiovascular death	—

Secondary

Measure	Time frame
i) all cause death ii) readmission due to worsening of heart failure iii) independent predictor for death and readmission due to worsening of heart failure iv) changes in serum creatinine level between at admission and discharge	—

Countries

Japan

Contacts

Public ContactKoichiro Matsumura

Kansai Medical University Medical Center Department of medicine II

kmatsumura1980@yahoo.co.jp06-6992-1001

Outcome results